1. Infection-resistant MRI-visible scaffolds for tissue engineering applications

Morteza Mahmoudi, Mingming Zhao, Yuka Matsuura, Sophie Laurent, Phillip C. Yang, Daniel Bernstein, Pilar Ruiz-Lozano*, Vahid Serpooshan*

Bioimpacts. 2016;6(2): 111-115. doi: 10.15171/bi.2016.16

PMCID: PMC4981249 PMID: 27525229 Scopus ID: 84983548259

Article

PDF

Full Text

XML

Cited By:

Original Research

2. High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy

Soheila Rostami , Farzaneh Tafvizi* , Hamid Reza Kheiri Manjili

BioImpacts. 2022;12(4): 301-313. doi: 10.34172/bi.2021.23337

PMCID: PMC9376161 PMID: 35975200 Scopus ID: 85138644192

Article

PDF

Full Text

XML

Cited By:

The findings suggest that F-Lys-TMX NPs are more effective and have the potential for cell proliferation inhibition and apoptosis induction compared to the TMX. Hence, F-Lys-TMX NPs can be considered as an anti-cancer agent against MCF-7 breast cancer cells.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons